Moreover, IDO inhibition by treatment with antisense or small molecule drugs including 1-methyl-tryptophan (1MT)[14], alone or in combination with FK866, could increase the therapeutic impact of NAD+ inhibition in tumor cells. Here, IDO1 is linked to neoplasm.